Companies / Century Therapeutics, Inc.
Century Therapeutics, Inc.
Financials · FY2025
Ownership
181.1M shares outstanding · as of Aug 3, 2026
Ownership
| Insiders | 3.26% | 5,910,691 |
| 10%+ / strategic | 7.45% | 13,486,400 |
| Institutions | 36.05% | 65,269,481 |
| Public float | 53.24% | 96,408,749 |
% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.
Insiders 4
View all →| Insider | % of shares | Shares |
|---|---|---|
Pfeiffenberger BrentCEOPresident and CEO · Director | 2.05% | 3,710,958 |
Cowan ChadChief Scientific Officer | 0.65% | 1,177,045 |
Russotti GregorySee Remarks | 0.28% | 515,427 |
Carr DouglasSVP Finance & Operations | 0.28% | 507,261 |
Institutional holders 57
View all →| Holder | Value | % of shares |
|---|---|---|
| $40.13M | 9.80% | |
| $19.82M | 4.47% | |
| $11.34M | 2.77% | |
| $10.55M | 2.58% | |
| $8.56M | 2.09% | |
| $5.93M | 3.29% | |
| $5.50M | 1.34% | |
| $5.36M | 1.31% | |
| $4.52M | 1.02% | |
| $2.94M | 0.72% |
Activity
InsidersInstitutions
What insiders are doing in this stock (Form 4).| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Mar 11, 2026 | Pfeiffenberger Brent CEO | Other | Common Stock | $151.2K | -55K -1.47% | 3,710,958 2.05% of shares | low |
| Feb 13, 2026 | Pfeiffenberger Brent CEO | Other | Common Stock | $54.6K | -31K -0.82% | 3,766,818 2.08% of shares | low |
| Mar 12, 2026 | Russotti Gregory Executive | Sell | Common Stock | $25.7K | -10K -1.92% | 515,427 0.28% of shares | low |
| Mar 12, 2026 | Carr Douglas Executive | Sell | Common Stock | $18.0K | -7K -1.37% | 507,261 0.28% of shares | low |
| Mar 11, 2026 | Cowan Chad Executive | Other | Common Stock | $3.9K | -1K -0.12% | 1,177,045 0.65% of shares | low |
| Jan 2, 2026 | Cowan Chad Executive | Other | Common Stock | $1.6K | -2K -0.15% | 1,043,476 0.58% of shares | low |
| Mar 9, 2026 | Russotti Gregory Executive | Sell | Common Stock | $1.2K | -479 -0.09% | 525,503 0.29% of shares | low |
| Mar 6, 2026 | Pfeiffenberger Brent CEO | Other | Common Stock | $1.2K | -463 -0.01% | 3,766,355 2.08% of shares | low |
5%+ ownership events
Schedule 13D / 13G
| Filer | Stance | % of class |
|---|---|---|
| RA Capital Management, L.P. | Passive13G | — |
| Point72 Asset Management, L.P. | Passive13G/A | — |
| Point72 Asset Management, L.P. | Passive13G | — |
| Venrock Healthcare Capital Partners III, L.P. | Passive13G | — |
| Commodore Capital LP | Passive13G | — |
| Deep Track Capital, LP | Passive13G | — |
| TCG Crossover GP II, LLC | Passive13G | — |
Securities
via CUSIP / OpenFIGI
| Symbol | Type | CUSIP |
|---|---|---|
| IPSC | Common Stock | 15673T100 |